(a) Hormone therapy including combination estrogen and hormone medicines, combination estrogen and progesterone medicines and estrogen-only medicines;
(b) SSRIs and SNRIs;
(c) Vaginal estrogen;
(d) Medications to prevent or treat osteoporosis;
(e) Neurokinin B antagonists;
(f) Topical hormone therapy; and
(g) Bioidentical hormones.
(2) The coverage required in this section is limited to drugs that have been approved by the United States Food and Drug Administration.
(3) This section is exempt from ORS 743A.001. [2025 c.500 §2]
Note: 743A.114 was added to and made a part of the Insurance Code by legislative action but was not added to ORS chapter 743A or any series therein. See Preface to Oregon Revised Statutes for further explanation.